ÂÜÀòÂÒÂ×

Elia Aguado Fraile is an accomplished professional in the field of translational science, currently serving as Associate Director at Repare Therapeutics since January 2021, where responsibilities include leading clinical biomarker strategy execution in Phase I clinical trials. Prior experience includes roles at Agios Pharmaceuticals as a Senior Scientist in Clinical Biomarkers and at the Molecular Oncology Research Institute, where research focused on cancer biology and epigenetics. Elia Aguado Fraile has a strong academic background with a PhD in Biology and a Master's degree in Molecular Biology and Biochemistry, both from Universidad Complutense de Madrid, along with a Bachelor's degree in Biology from Universidad de Alcalá.